The University of Chicago Header Logo

Connection

Wendy Stock to Drug Evaluation

Back to Details
This is a "connection" page, showing publications Wendy Stock has written about Drug Evaluation.
Wendy Stock
Connection Strength
0.081
Drug Evaluation
  1. Histone deacetylase inhibitor romidepsin has differential activity in core binding factor acute myeloid leukemia. Clin Cancer Res. 2008 Nov 01; 14(21):7095-101.
    View in: PubMed
    Score: 0.081
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.